Magic Empire Global Limited (NASDAQ:MEGL) +100%; recent IPO extends gain after surging in debut.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) +53%; today announced positive topline results from its Phase 3 EMERGENT-2 trial evaluating the efficacy, safety, and tolerability of its lead investigational therapy, KarXT (xanomeline-trospium), in adults with schizophrenia. The trial met its primary endpoint, with KarXT demonstrating a statistically significant and clinically meaningful 9.6-point reduction in the Positive and Negative Syndrome Scale (PANSS) total score compared to placebo (-21.2 KarXT vs. -11.6 placebo, p<0.0001) at Week 5 (Cohen’s d effect size of 0.61). KarXT also demonstrated an early and sustained statistically significant reduction of symptoms, as assessed by PANSS total score, starting at Week 2 and maintained such reduction through all timepoints in the trial.
Bed Bath & Beyond (NASDAQ:BBBY) +40% on continued momentum in meme stocks,
AMC Entertainment (NYSE:AMC) also higher, +7%.
CyberOptics Corporation (NASDAQ:CYBE) +30%; Nordson Corporation (NASDAQ:NDSN) has signed a definitive agreement for the acquisition of CyberOptics Corporation, a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions. The all-cash transaction is valued at $54.00 a share, or approximately $380 million net of cash acquired, reflecting a valuation of 18.5 times CyberOptics trailing twelve months EBITDA, and 14.5 times net of cost synergies.
Kodiak Sciences, Inc. (NASDAQ:KOD) +30%; today announced that its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab), its novel antibody biopolymer conjugate, met the primary endpoint of non-inferior change from baseline in visual acuity at week 24 compared to aflibercept in patients with macular edema due to retinal vein occlusion. Tarcocimab also demonstrated robust anatomic responses and a favorable safety profile. After two initial monthly loading doses, tarcocimab was dosed every two months compared to consistent monthly dosing for aflibercept.
Signify Health, Inc. (NYSE:SGFY) +20%; CVS is planning to bid for Signify Health , according to a report in the Dow Jones.
Coinbase (NASDAQ:COIN) +9%; related names climb as Bitcoin tops $24,000.
MicroStrategy Incorporated (NASDAQ:MSTR) +6.5%
Riot Blockchain (NASDAQ:RIOT) +7%
Marathon Digital Holdings (NASDAQ:MARA) +8%
First Solar (NASDAQ:FSLR) +6%, Upgraded at JPMorgan (NYSE:JPM) and Guggenheim.
Palantir (NYSE:PLTR) -15%; Guidance misses consensus.
Roku (NASDAQ:ROKU) -2%; cut to sell at Pivotal Research.